Keratoconus clinical trials
23 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
- Intacs Prescription Inserts for Keratoconus Patients
- Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
- Collagen Cross-linking in Keratoconus
- Comparison of Standard vs. Accelerated Corneal Crosslinking
- Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
- Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
- Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
- Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning
- fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
- The K-Map Study, Global Prevalence of KC
- Corneal Elastography and Patient Specific Modeling
- A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- Scleral Lens Fitting Using Wide-Field OCT
- OCT in Diagnosis of Irregular Corneas
- OCT Vibrography for Biomechanical Properties of Tissues
- A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients
- Assessing Patient Engagement in Keratoconus Clinical Research
- Outcomes of CTAK Surgery
- Corneal Biomechanical Analysis Using Brillouin Microscopy
- Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking
- Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Keratoconus” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.